HOXA13 and colorectal carcinoma: The results indicated that HOXA13 mRNA and protein expression was higher in CRC cells that have the high capabilities to metastasis (LoVo and SW620) than those that have low metastatic capabilities (SW480 and DLD-1) (Fig. 1E).